GW Pharmaceuticals Plc Financials

GW Pharmaceuticals Stock Summary

GW Pharmaceuticals competes with Harmony Gold, Old Republic, Perseus Mining, Vindicator Silver, and Summit Materials. GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom. Gw Pharma operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 1161 people.

GW Pharmaceuticals Key Financial Ratios

Generally speaking, GW Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from GW Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of GW Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that GW Pharmaceuticals Plc reports annually and quarterly.

GWPH Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining GW Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare GW Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GW Pharmaceuticals competition to find correlations between indicators driving GW Pharmaceuticals's intrinsic value. More Info.GW Pharmaceuticals Plc is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value GW Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GW Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GW Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.